Sonoma Pharmaceuticals Stock Technical Analysis

SNOA Stock  USD 0.16  0.01  6.67%   
As of the 25th of April, Sonoma Pharmaceuticals has the Semi Deviation of 4.72, risk adjusted performance of 0.0183, and Coefficient Of Variation of 6688.42. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sonoma Pharmaceuticals, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Sonoma Pharmaceuticals, which can be compared to its competition. Please validate Sonoma Pharmaceuticals variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Sonoma Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 0.16 per share. As Sonoma Pharmaceuticals appears to be a penny stock we also recommend to double-check its total risk alpha numbers.

Sonoma Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sonoma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Sonoma
  
Sonoma Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Sonoma Pharmaceuticals Analyst Consensus

Target PriceAdvice# of Analysts
3.25Strong Buy1Odds
Sonoma Pharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Sonoma analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sonoma stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sonoma Pharmaceuticals, talking to its executives and customers, or listening to Sonoma conference calls.
Sonoma Analyst Advice Details
Sonoma Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sonoma Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sonoma Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Sonoma Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sonoma Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Sonoma Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Sonoma Pharmaceuticals. You can use it to identify possible trend reversals for Sonoma Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sonoma Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Sonoma Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Sonoma Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of    , which may suggest that Sonoma Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Sonoma Pharmaceuticals price change compared to its average price change.

About Sonoma Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sonoma Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sonoma Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sonoma Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Sonoma Pharmaceuticals. By analyzing Sonoma Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sonoma Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sonoma Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.350.36
Price To Sales Ratio0.290.27

Sonoma Pharmaceuticals April 25, 2024 Technical Indicators

Most technical analysis of Sonoma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sonoma from various momentum indicators to cycle indicators. When you analyze Sonoma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Sonoma Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonoma Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonoma Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonoma Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonoma Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Sonoma Stock refer to our How to Trade Sonoma Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Sonoma Stock analysis

When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Sonoma Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonoma Pharmaceuticals. If investors know Sonoma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonoma Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.82)
Revenue Per Share
1.946
Quarterly Revenue Growth
0.066
Return On Assets
(0.19)
Return On Equity
(0.83)
The market value of Sonoma Pharmaceuticals is measured differently than its book value, which is the value of Sonoma that is recorded on the company's balance sheet. Investors also form their own opinion of Sonoma Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Sonoma Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonoma Pharmaceuticals' market value can be influenced by many factors that don't directly affect Sonoma Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonoma Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonoma Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonoma Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.